Occidental Petroleum Corp. Q3 Profit Decreases
AstraZeneca lifts 2024 outlook after Q3 beat, doubles down on US investments
Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong demand for its cancer and rare diseases medicines, after third-quarter results beat estimates.
"Malaysia will likely show resilient economic growth in Q3. The services sector likely experienced a robust, broad-based ...
Spotify cranked up the volume with another strong quarter, packing on 6 million paying subscribers globally in Q3 2024.
Axsome Therapeutics' Q3 2024 earnings report shows a revenue beat with $104.8m. See why I think selling AXSM stock on any ...
AstraZeneca's Q3 sales rose 18% YoY to $13.6 billion Adjusted EPADS hit $1.04, exceeding expectations. U.S. investment of ...
The latest update is out from Rumble ( (RUM)). Rumble Inc. has reported a strong third quarter in 2024, with a 39% increase in revenue to $25.1 million and a 26% rise in monthly active users to 67 ...
NWN earnings call for the period ending September 30, 2024. Northwest Natural ( NWN 1.62%) Q3 2024 Earnings Call Nov 12, 2024 ...
Hosted on MSN19h
AstraZeneca lifts 2024 revenue and profit forecast after Q3 beat(Reuters) - Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time in less than four months on ...
Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ETCompany ParticipantsJohn Givens - CEOAlanna Boudreau ...
Sea Limited beat expectations in Q3, showcasing notable growth on top and bottom lines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback